EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence

Xue Zhao iD, Shinichi Sakamoto, Yasutaka Yamada, Kodai Sato, Takaaki Tamura, Hiroki Shibata, Tomokazu Sazuka iD, Yusuke Imamura, Tomohiko Ichikawa

International Journal of Urology · 2025

DOI: 10.1111/iju.70125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Urology, 2025. Verfasst von Xue Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Testosterone, Prostatic Neoplasms, Androgen Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 133 Literaturangaben. Gefördert von: Grant-in-Aid for Scientific Research (C), Japan China Sasakawa Medical Fellowship, JST SPRING.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum testosterone plays a pivotal role in the pathogenesis and treatment of prostate cancer, influencing tumor growth and progression. This review synthesizes current clinical evidence on the dual role of serum testosterone as both a biomarker of carcinogenesis and a target for therapeutic intervention. We discuss the mechanisms linking androgen signaling to prostate cancer development, emphasizing the role of testosterone in androgen receptor activation and cellular proliferation. Furthermore, we explore the clinical implications of testosterone suppression strategies, including androgen deprivation therapy (ADT) and bipolar androgen therapy (BAT), highlighting their impact on patient outcomes. Emerging evidence on the prognostic significance of nadir testosterone levels, testosterone rebound, and treatment resistance is also analyzed. Finally, we address the challenges and opportunities in testosterone monitoring, aiming to enhance precision medicine approaches for managing prostate cancer. This review underscores the importance of personalized testosterone‐based strategies to optimize therapeutic outcomes and improve patient quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneProstatic NeoplasmsAndrogen AntagonistsHumansMaleReceptors, AndrogenBiomarkers, TumorPrognosisDisease ProgressionPrecision MedicineQuality of Life

Stichwörter der Autor:innen

androgen deprivation therapybipolar androgen therapyprognosisprostate cancertestosterone

Substanzen

TestosteroneAndrogen AntagonistsReceptors, AndrogenBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.

ORCID-Profile: Xue Zhao, Tomokazu Sazuka

Förderung

  • Grant-in-Aid for Scientific Research (C)
  • Japan China Sasakawa Medical Fellowship
  • JST SPRING

Zitieren

APA

Zhao, X., Sakamoto, S., Yamada, Y., Sato, K., Tamura, T., Shibata, H., Sazuka, T., Imamura, Y., & Ichikawa, T. (2025). The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence. International Journal of Urology. https://doi.org/10.1111/iju.70125

Vancouver

Zhao X, Sakamoto S, Yamada Y, Sato K, Tamura T, Shibata H, et al. The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence. International Journal of Urology. 2025. doi:10.1111/iju.70125

BibTeX
@article{Zhao2025,
  author = {Zhao, Xue and Sakamoto, Shinichi and Yamada, Yasutaka and Sato, Kodai and Tamura, Takaaki and Shibata, Hiroki and Sazuka, Tomokazu and Imamura, Yusuke and Ichikawa, Tomohiko},
  title = {The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence},
  journal = {International Journal of Urology},
  year = {2025},
  doi = {10.1111/iju.70125}
}
Kostenlos starten →